SIBO - Small Intestinal Bacterial Overgrowth

Lara Spector
ND
https://www.laraspectornd.com
13 February 2016

Language English

Small intestinal bacterial overgrowth (SIBO) is characterized by an overgrowth of various types of bacteria in the small intestine, bacteria which are largely only found in the colon. SIBO was initially thought of as a rare condition; however, it is now recognized as a more prevalent digestive disorder than previously acknowledged. A meta-analysis has shown the prevalence of SIBO to be approximately 64% among patients with irritable bowel syndrome (IBS).^[1] The symptoms of SIBO vary, from mild (constipation, gas, bloating) to suffering from chronic diarrhea, weight loss, and malabsorption. It has been realized that the symptoms of SIBO closely overlap symptoms of IBS, which allows for most patients to be wrongly diagnosed with IBS.

Definition

SIBO is defined as a bacterial population in the small intestine that exceeds 105–106 organisms per millilitre and contains certain types of organisms, specifically coliform bacteria.^[2] The large intestine contains an average count of 1014 bacteria per millilitre, which is where the majority of the gut microbiota resides. To compare, the small intestine normally contains less than 105 bacteria per millilitre, and most of these are Gram-positive aerobic bacteria (Figure 1). This low amount of bacteria in the small intestine is due to sufficient gastric acid secretion, normal peristalsis, normal secretory IgA levels, and an intact ileocecal valve.^[4]

Etiology and Pathophysiology

SIBO occurs most commonly when there is abnormal gastric acid secretion and/or intestinal clearance, which result in deviant bacterial migration in the GI tract. Some conditions that predispose patients towards the development of SIBO include achlorhydria (from autoimmune or iatrogenic causes or surgery), diverticulosis, systemic diseases (e.g. celiac disease, Crohn’s disease), intestinal obstruction, immune deficiency states (including secretory IgA deficiency), and alcoholism.^[1] The elderly population is more susceptible, as gastric acid production decreases with age. Once the bacterial overgrowth has been established, an inflammatory response to this dysbiosis occurs in the intestinal mucosa, caused by the bacteria’s toxic by-products. Analysis of small-intestine biopsies in the elderly diagnosed with SIBO has shown blunting of the intestinal villi, thinning of the mucosa, and increased white blood cells.^[2]

Symptoms and Signs Explained

Symptoms associated with bacterial overgrowth include bloating, abdominal pain or discomfort, diarrhea, constipation, fatigue, weakness, and abdominal distension. The severity of symptoms reflects the amount of overgrowth as well as the extent of inflammation in the small intestine.^[2] The symptoms of SIBO can be nonspecific, which can make it difficult to differentiate from conditions such as IBS, lactose or fructose intolerance, celiac disease, or Crohn’s disease. In patients with SIBO, carbohydrates ingested will be fermented by the excess bacteria in the small intestine, which leads to increased gas production resulting in bloating and flatulence.^[5] The gases produced include hydrogen and methane. Evidence suggests that excessive methane is produced by this overgrowth, and the presence of methane results in constipation.^[6] Studies show that a reduction in breath methane by modification of the gut flora improves this constipation.^[6] On the other hand, the thinning of the mucosa caused by the bacterial overgrowth has been shown to increase the osmotic load, resulting in diarrhea. Studies have demonstrated that IBS patients with confirmed SIBO more often have diarrhea-predominant IBS.^[6]

Complications of SIBO

The symptoms of SIBO can reflect the complications of the condition, including motility issues, malabsoprtion, and nutritional deficiencies. The complications of SIBO vary from mild digestive discomfort to severe malabsorption issues, leading to multiple nutrient deficiencies, especially fat-soluble vitamin deficiencies. Deficiencies in fat-soluble vitamins occur from poor absorption as a result of bacterial deconjugation of bile salts. Symptoms of severe deficiency can include night blindness (vitamin A), osteomalacia (vitamin D), prolonged prothrombin times (vitamin K), and immune impairments from altered T-cell functioning.^[2]Vitamin B12 deficiency is a common complication of SIBO. Studies with human subjects with atrophic gastritis and bacterial overgrowth absorbed less vitamin B12 compared to controls. This deficiency was reversed with antibiotic therapy, indicating the importance of modifying gut flora as a treatment.^[2]Carbohydrate and protein malabsorption commonly occur as well, due to the premature fermentation and breakdown by the excess bacteria in the small intestine.

Diagnosis

Diagnosis of SIBO is difficult and controversial, due to the low specificity of the symptoms and absence of definitive objective diagnostic tests. Two tests are used to diagnose SIBO: bacterial culture and the more predominant method, breath tests.^[2] The most direct method of assessing the bacteria in the gut is the quantitative measurement of bacteria counts via culture. However, this method requires an invasive and costly endoscopic procedure and commonly encountered problems include contamination, difficulty aspirating a sufficient sample, and introduction of air into the lumen of the duodenum.^[2]The challenges of this method led to the development of indirect methods of measuring small-bowel bacteria and diagnosing SIBO. Breath-testing is now the most common method to assess patients for SIBO. The breath tests used all rely on the measurement of exhaled gases produced by the bacteria’s metabolism of an ingested substrate (usually a simple carbohydrate such as lactulose, glucose, sucrose, or xylose). Patients are generally instructed to avoid eating unfermentable complex carbohydrates and to fast overnight. After an overnight fast, a hydrogen and/or methane sample is taken, and then the patient consumes 10 g of lactulose or 50–80 g of glucose administered in a small glass of water. Breath samples are then collected every 15–30 minutes for a total of 3–4 hours.^[2]There are a few complications with the SIBO breath test, including a lack of consensus regarding what the gold standard is for diagnosing SIBO, as well as fairly high rates of false negatives.^[2]

Treatment

The therapeutic approach to SIBO involves addressing the predisposing condition and is supported by antibiotics (herbal and/or conventional), probiotics, and diet modification. The goal of therapy is to restore normal small intestinal flora and additionally, to correct any nutritional deficiencies.

“An ounce of prevention is worth a pound of cure.”
—Benjamin Franklin

Protective factors that prevent the development of SIBO include adequate gastric acid production and secretion, pancreatic enzymes, proper motility and elimination, biofilm, sufficient secretory IgA, and bile acids.^[1]Once the diagnosis for SIBO has been confirmed, the standard treatment involves a course of the antibiotic rifaximin (1200 mg a day for 10–14 days). Rifaximin is the most commonly studied treatment for SIBO, and has shown a breath-test resolution rate of 49.5% in eight clinical trials. However, a meta-analysis showed that the therapeutic efficacy of this antibiotic in the long term was only 9.8%.^[1] Antibiotics are also well-known to have a wide range of toxicity, adverse effects, and resistance; also, recurrence rates after rifaximin treatment has been shown to be high.^[1] A clinical trial showed the combination of rifaximin with partially hydrolysed guar gum seems to reduce the recurrence rates of SIBO compared to rifaximin alone.^[7]A study compared the efficacy of herbal therapy to antibiotic therapy in the setting of SIBO.^[1] The study’s response rate for normalizing breath hydrogen testing in patients with SIBO was 46% for herbal therapies v. 34% for rifaximin. In this study, a combination of antimicrobial herbs was used including berberine extracts, oil of oregano, wormwood, and Thymus vulgaris. The researchers concluded that patients receiving antibiotic or herbal therapy received a similar response rate and safety profile. They also found that in patients refractory to rifaximin, herbal therapy serves as a potential therapy with equivalent efficacy to triple antibiotics.^[1]Some studies support the use of probiotics as an effective treatment for IBS; however, attempts at treating SIBO with probiotics have shown mixed results. One study using Lactobacillus showed an improvement in symptoms and a reduction in hydrogen breath levels; however, other studies have not shown improvements.^[2]

A diet low in fermentable oligosaccharides, disaccharides, monosaccharides. and polyols (FODMAPs) was shown to reduce the symptoms of IBS and have marked effects on gut microbiota. The long-term effects of a low intake of FODMAPs require further study.^[8]

Conclusion

The human body contains at least ten times more microbial cells than human cells, with most of these cells concentrated in the gastrointestinal tract.^[3] There is more recent interest in the microbiome, more specifically the gut flora and its relation to intestinal function and the development of various diseases. Given the role of the gut microbiome in disease, SIBO is an important gastroenterological condition to identify and treat. Studies thus far reveal encouraging results on modifying the gut flora as a therapeutic modality for SIBO, and further investigations are necessary to reveal the optimal and most successful diagnostic and treatment tools.

References

Chedid, V. and S. Dhalla. “Herbal therapy is equivalent to rifaximin for the treatment of small intestinal bacterial overgrowth.” Global Advances in Health and Medicine : Improving Healthcare Outcomes Worldwide Vol. 3, No. 3 (2014): 16–24.
Dukowicz, A.C. and E. Lacy. “Small intestinal bacterial overgrowth: A comprehensive review.” Gastroenterology & Hepatology Vol. 3, No. 2 (2007): 112–122.
Vanderhoof, J.A. and R. Pauley-Hunter. “Small Intestinal Bacterial Overgrowth,” pp. 487–494 in Guandalini, S., A. Dhawan, and D. Branski, eds., Textbook of Pediatric Gastroenterology, Hepatology and Nutrition. Cham, Switzerland: Springer International Publishing, 2016, 913 pages.
Ruiz, A.R. “Bacterial overgrowth syndrome.” Merck Manual—Professional Version · http://www.merckmanuals.com/professional/gastrointestinal-disorders/malabsorption-syndromes/bacterial-overgrowth-syndrome · Updated 2014‑05 · Accessed 2015‑12.
Gasbarrini, A., et al. “Small intestinal bacterial overgrowth: Diagnosis and treatment.” Digestive Diseases Vol. 25, No. 3 (2007): 237–240.
Ghoshal, U.C. and D. Srivastava. “Irritable bowel syndrome and small intestinal bacterial overgrowth: Meaningful association or unnecessary hype.” World Journal of Gastroenterology Vol. 20, No. 10 (2014): 2482–2491.
Furnari, M., et al. “Clinical trail: The combination of rifaximin with partially hydrolysed guar gum is more effective than rifaximin alone in eradicating small intestinal bacterial overgrowth.” Alimentary Pharmacology & Therapeutics Vol. 32, No. 8 (2010): 1000–1006.
Halmos, E.P., et al. “Diets that differ in their FODMAP content alter the colonic luminal microenvironment.” Gut Vol. 64, No. 1 (2015): 93–100.

Mouth Health, Microbial Dysbiosis, and the Connection to Systemic Health and Disease
15 Jun 21
Our knowledge of connections between the human microbiome, immune system, and disease continue to evolve. Gut microbiota are influential in the health of our bodies and function to both increase immune-system function and suppress colonization of pathogens.
Gluten and Its Impact on Chronic Disease
27 Jan 21
Emerging health implications of gluten sensitivity reach far beyond the borders of the gastrointestinal tract. The gluten-sensitive spectrum includes different forms of manifestations: allergic (wheat allergy), autoimmune celiac disease (CD), dermatitis herpetiformis, gluten ataxia, and immune-mediated (nonceliac gluten sensitivity).
Probiotics. Part 2/2
29 Apr 22
Probiotics have extensive potential for therapeutic use, and we continue to discover their specific actions. The previous article looked at classification and the role of probiotics with regards to immune function and digestion, including autoimmunity, atopic skin reactions, and respiratory conditions.
Reversing Metabolic Syndrome Using Natural Medicine
12 Feb 20
Metabolic syndrome is a cluster of risk factors that increase one’s chances of developing serious illnesses in the future. Metabolic syndrome doubles the chance of developing cardiovascular disease while increasing the risk of diabetes, fatty liver, and several types of cancers.[1][2]
The Gut–Lung Microbiome Axis A Bidirectional Immune Highway
10 Jun 20
By now, most of us have heard the word microbiome—the collection of trillions of functional bacteria of all different species found in many places throughout our bodies, such as our skin, gut, mouth, vagina, and lungs.
The Gut Microbiome and Health - Naturopathic Perspectives
09 Mar 20
The human gastrointestinal tract (GIT) alone contains 1014 microorganisms including bacteria, viruses, and fungi. That’s approximately 100 times more microbial cells than human cells, which shows how much of an impact they can have on human health.
Eating Fat Isn’t the Only Thing Causing Fatty Liver Disease
10 Jun 20
In many countries around the world, alcoholic beverages are built into the culture and religion. We consume it as a form of celebration and a form of self-medication. But over the years, it takes a toll on our organ system that works to filter it out. Fatty liver disease is a growing concern in the Western hemisphere, especially as new diagnoses include people of normal body weights and people who don’t drink alcohol.
Collagen - What Is It and What Are the Health Benefits?
17 Dec 19
Collagen peptides have seemingly appeared out of nowhere. They are being advertised on social media, can be found on the covers of magazines… even my hairdresser has been talking about how she adds collagen peptides to her smoothie! But what are collagen peptides? Why is everyone adding this powder to their coffee, smoothies, or breakfast oatmeal bowl? And the real question is: Should you be adding collagen peptides to your diet as well?
Celiac Disease and Gluten Sensitivity - Should we be worried?
02 Jul 14
Consumption of wheat has increased dramatically over the last decades. Wheat was once thought to be an important part of a healthy diet, but now is seen as a potential health threat for many individuals. Gluten is a food component found in wheat, rye, barley, and cereals. More specifically, it is a protein complex that is formed by gliadin and glutenin, typically used in processed foods as a stabilizing agent. Celiac disease (CD) is a complex chronic immune-mediated disorder whose gastrointestinal symptoms are triggered by eating gluten.
Sweet Almond Oil - Clinical Applications
13 Apr 17
Sweet almonds, when ingested, provide dietary fibre and healthy fats that are good for overall health and may be helpful for reducing cholesterol and decreasing the risk of coronary heart disease.
Crohn’s Disease
17 Jun 16
Crohn’s disease (CD) is a chronic inflammatory disorder of the gastrointestinal tract. It is one of two conditions classified as inflammatory bowel disease (IBD), the other condition being ulcerative colitis (UC). UC is limited to the colon, while CD can involve any segment of the gastrointestinal tract from the mouth to the anus.
Food Sensitivities - What You Need to Know
06 Oct 16
Did you know many people are sensitive to foods without even knowing it? Food sensitivities can manifest in the body in a variety of different ways, such that two unique individuals will not necessarily experience the exact same symptoms.
Gastroesophageal Reflux Disease
16 Jan 16
Gastroesophageal Reflux Disease or GERD can be defined as a condition of mucosal damage produced by the abnormal reflux of gastric contents into the esophagus. According to the Canadian Digestive Health Foundation, 5 million Canadians experience heartburn and/or acid regurgitation at least once each week.
Irritable Bowel Syndrome
22 Dec 15
Irritable bowel syndrome (IBS) is a gastrointestinal disorder characterized by irregular bowel habits and abdominal pain. ^[1] Four subtypes of IBS have been identified: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D), mixed IBS (IBS-M), and un-subtyped IBS. One subtype is not completely independent of the others, for example, patients with IBS-C will most likely experience IBS-D as well at some point in their lives.
Constipation - 10 Anti-Constipation Tips
12 Apr 17
Bowel movements provide information not only about the workings of your digestive system, but also about so many other aspects of your health.
Autism - The Role of the Microbiome
13 Feb 16
The human microbiome is defined as the full collection of genes of all the microbes in the human body and “consists of 10–100 trillion symbiotic microbial cells,” outnumbering the number of human cells by ten times. An individual’s genome is 99.9% identical to another human’s; however, their microbiomes will only show 10–20% similarity to one another.
Benefits of Acupuncture for Cancer Patients
17 Jun 16
The use of complementary medicine for the treatment of cancer and its side effects has skyrocketed in recent years. Complementary therapies refer to ones that are nonpharmaceutical in nature, and that have the potential to not only enhance quality of life, but also to reduce side effects of conventional therapy.
Gut Health
07 May 15
The immune system is able to discriminate self from non-self antigens, substances that trigger the immune system, which protects the host from infections and cancer. Autoimmune diseases are characterized by deregulated immune responses. Autoimmune diseases affect 5-8% of the population in the United States and can affect almost every site in the body
The Importance of Optimizing Digestion - Natural Treatment Strategies
19 Sep 17
The gastrointestinal (digestive) system is complex. The process of digestion follows sequential steps and must function properly in order for the body to get the nutrients it requires for optimal health.
Rheumatoid Arthritis - Naturopathic Perspectives
11 Oct 18
A fairly common chronic condition that afflicts people is rheumatoid arthritis (RA); a form of chronic joint inflammation that can have major impact on quality of life. The exact cause of rheumatoid arthritis is unknown, but it has a significant autoimmune component. This is how it differs starkly from the much more common osteoarthritis, which is more of a “wear-and-tear” form of arthritis that results from mechanical use of joints over a long and active life. Rheumatoid arthritis not only affects the joints, but also presents with systemic inflammatory symptoms.